Investor

HBM BioVentures

Last cheque observed Nov 2013. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

QuietGrowth equity

Series BSeries CSeries A

Cheques on record
0%of best year0cheques in 12 months, 60 on record
Since the last cheque4737days00hrs00min00sec
Median round$25MRounds led0 of 60Sole investor1 roundsExits7 from the portfolioMostly inUnited States, 72%
Pitch HBM BioVentures

HBM BioVentures highlights

  1. 01

    60 rounds on record

  2. 02

    Mostly Series B and Series C: 47% of its rounds

  3. 03

    Sole investor in 1 rounds, median $1.9M

  4. 04

    7 exits from the portfolio

What they do

Type
Growth equity (from a list, unverified)
Cheque size
Not stated
Cold pitches
Not stated

The record

Every round we can evidence, newest first60 appearances

  1. 2013

    1 round

  2. Nov
    Delenex TherapeuticsSeries A · CH · startupticker.ch$8.0MWith 4 others
  3. 2012

    2 rounds

  4. Jul
    PTC TherapeuticsGrowth · US · finsmes.com$30MWith 4 others
  5. Jan
    ProbiodrugVenture · DE · finsmes.com$19MWith 5 others
  6. 2011

    2 rounds

  7. Aug
    Ellipse TechnologiesSeries C · US · finsmes.com$18MWith 3 others
  8. May
    Delenex TherapeuticsSeries A · CH · finsmes.com$19MWith 5 others
  9. 2010

    6 rounds

  10. Nov
    VivactaGB · finsmes.com$6.4MWith 3 others
  11. Nov
    Delenex TherapeuticsSeries A · CH · finsmes.com$14MWith 4 others
  12. Nov
    MTM LaboratoriesSeries C · US · finsmes.com$9.7MWith 2 others
  13. Sept
    Cylene PharmaceuticalsSeries D · US · socaltech.com$12MWith 6 others
  14. Jun
    Nereus PharmaceuticalsSeries E · US · onbiovc.com$20MWith 6 others
  15. Jan
    Nabriva TherapeuticsSeries B · AT · onbiovc.com$22MWith 7 others
  16. 2009

    8 rounds

  17. Dec
    PTC TherapeuticsSeries E · US · finsmes.com$50MWith 4 others
  18. Dec
    PTC TherapeuticsGrowth · US$50MWith 4 others
  19. Dec
    OphthotechSeries B · US · fiercebiotech.com$30MWith 3 others
  20. Nov
    ProbiodrugSeries B · DE · probiodrug.de$54MWith 7 others
  21. Oct
    Kolltan PharmaceuticalsSeries A · US · onbiovc.com$5.0MWith 1 other
  22. Oct
    MTM LaboratoriesSeries C · US · mtmlabs.com$57MWith 3 others
  23. Oct
    Lux BiosciencesSeries B · US · venturebeat.com$50MWith 3 others
  24. Aug
    Zosano PharmaSeries B · US · onbiovc.com$30MWith 3 others
  25. 2008

    5 rounds

  26. Aug
    ESBATechSeries B · CH · fiercebiotech.com$22MWith 7 others
  27. Jul
    Kolltan PharmaceuticalsSeries A · US$40MWith 4 others
  28. Jul
    Broncus Technologies, Inc.Debt · USUndisclosedWith 2 others
  29. Jul
    MiCardia CorporationVenture · US$5.0MWith 1 other
  30. Jan
    Genizon BioSciencesSeries E · CA · genizon.com$31MWith 3 others
  31. 2007

    15 rounds

  32. Dec
    Pelikan TechnologiesSeries F · US · venturebeat.com$69MWith 2 others
  33. Nov
    VivactaSeries B · GB$12MWith 3 others
  34. Nov
    Zosano PharmaSeries A · US · zosanopharma.com$90MWith 3 others
  35. Nov
    Sloning BioTechnologySeries E · DE · sloning.com$6.8MWith 3 others
  36. Oct
    Vital TherapiesSeries C · US$28MWith 3 others
  37. Aug
    OphthotechSeries A · US$36MWith 2 others
  38. Aug
    Nereus PharmaceuticalsSeries D · US$45MWith 12 others
  39. Aug
    AdnexusSeries C · US · adnexustx.com$16MWith 4 others
  40. Jul
    AgensysSeries D · US · agensys.com$41MWith 10 others
  41. May
    Interventional SpineSeries C · US$24MWith 3 others
  42. May
    BaroFoldSeries A · US · venturebeat.com$12MWith 2 others
  43. Mar
    Surface LogixSeries D · US$20MWith 4 others
  44. Mar
    ChemoCentryxSeries D · US · deals.venturebeat.com$30MWith 4 others
  45. Feb
    Locus PharmaceuticalsSeries E · US$30MWith 3 others
  46. Jan
    Cylene PharmaceuticalsSeries C · US · rctech.com$44MWith 7 others
  47. 2006

    5 rounds

  48. Dec
    Cathay Industrial BiotechSeries B$52MWith 4 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

Exits from the portfolio

Companies it backed that were later bought or listed7 in all

PTC TherapeuticsListed$125MJun 2013
MTM LaboratoriesBought by RocheUndisclosedJul 2011
Surface LogixBought by Nano TerraUndisclosedApr 2011
Sloning BioTechnologyBought by MorphoSysUndisclosedOct 2010
AdnexusBought by Bristol-Myers Squibb$415MAug 2010
BiovitrumBought by Swedish Orphan Biovitrum$493MNov 2009
AdnexusBought by Bristol-Myers Squibb$415MSept 2007

An exit counts when it came after the firm's first round in the company. From historical deal records.

Companies it bought

Acquisitions by the firm itself

New Medical TechnologiesUndisclosedFeb 2003

Who they invest alongside

The investors most often in the same rounds as HBM BioVentures. A count of rooms they were both in, not a relationship either has claimed.

Alta PartnersVC firm10rounds togetherNovo Holdings A/SGrowth equity10rounds togetherSV Life SciencesVC firm9rounds togetherDelphi VenturesVC firm7rounds togetherHBM BioCapitalInvestment firm6rounds togetherBioMedPartnersPrivate equity5rounds togetherGimvPrivate equity5rounds togetherMedFocus FundFund of funds5rounds togetherNovartis Venture FundCorporate VC5rounds togetherOrbiMedPrivate equity5rounds togetherVI PartnersVC firm5rounds togetherClarus VenturesVC firm4rounds together

Quick answers about HBM BioVentures

What does HBM BioVentures invest in?

HBM BioVentures invests most often at Series B and Series C (47% of the rounds on record).

How active is HBM BioVentures?

60 investments on record, 0 of them in the last 12 months. The most recent was in Nov 2013.

How big are HBM BioVentures's cheques?

The median round it joins is $25M.

Does HBM BioVentures lead rounds?

Rarely, if at all: none of its 60 investments on record names it as the lead.

Where does HBM BioVentures invest?

Most of the companies it backs are in the United States (72%), Switzerland (10%) and Germany (8%).

Is HBM BioVentures investing now?

No investments in the last 12 months; the latest was in Nov 2013.

Who does HBM BioVentures invest alongside?

Most often Alta Partners (10 rounds together), Novo Holdings A/S (10 rounds together) and SV Life Sciences (9 rounds together).

What kind of investor is HBM BioVentures?

HBM BioVentures is a growth equity firm.

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it